SCHEMBL4782498

SCHEMBL4782498

CC(=O)OC[C@H]1O[C@H](OC(C)[C@H](N)C(=O)O)[C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 4/20 0.55
▸ THRB P10828 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ CA2 P00918 8/20 0.48
▸ TSHR P16473 1/20 0.48
▸ CA12 O43570 7/20 0.47
▸ CA1 P00915 6/20 0.47
▸ CA9 Q16790 5/20 0.47
▸ NR3C1 P04150 1/20 0.45
▸ FYN P06241 1/20 0.45
▸ ADRA2A P08913 1/20 0.45
▸ ADORA3 P0DMS8 1/20 0.45
▸ ADRA2B P18089 1/20 0.45
▸ DRD4 P21917 1/20 0.45
▸ DRD3 P35462 1/20 0.45
▸ CA4 P22748 2/20 0.45
▸ CA5A P35218 2/20 0.45
▸ CA7 P43166 2/20 0.45
▸ CA5B Q9Y2D0 2/20 0.45
▸ MAPK1 P28482 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4782512 1.00 CYP2D6 (0.55) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL14049596 0.87 LMNA (0.56) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL14031247 0.87 LMNA (0.56) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL17748366 0.83 CYP2D6 (0.64) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL25783116 0.83 CYP2D6 (0.64) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL27252408 0.82 CYP2D6 (0.63) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL6570136 0.82 CYP2D6 (0.63) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL7220108 0.81 CYP2D6 (0.61) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL26124550 0.81 CYP2D6 (0.61) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL6234936 0.80 CYP2D6 (0.57) CYP2D6THRBHSD17B10CA2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008011168-A2 GLYCOSYLATED PEPTIDE ANTAGONISTS OF THE BRADYKININ B1 RECEPTOR AMGEN INC. (US) 2008-01-24 — — WO disclosed
Send feedback